Header Logo

Connection

GLADSTONE AIREWELE to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Clinical Trials, Phase III as Topic.
GLADSTONE AIREWELE
Connection Strength
0.047
Clinical Trials, Phase III as Topic
  1. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.